Full-Time

Content Partner Training Manager

Confirmed live in the last 24 hours

Veeva Systems

Veeva Systems

5,001-10,000 employees

Quality and regulatory software solutions provider

Compensation Overview

$65k - $110k/yr

+ Variable Bonus + Stock Bonus

Mid, Senior

Company Historically Provides H1B Sponsorship

Boston, MA, USA

Category
Training
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Veeva Systems referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Bachelor’s degree or equivalent experience
  • 3+ years of educating people on technical enterprise software solutions. This experience may be pure training/instructional design work or may be system implementation/consulting work with a heavy emphasis on training
  • Proven ability to quickly learn industry terminology, processes, and systems in order to design and develop effective training courses
  • Proven ability to build and maintain relationships with subject matter experts and align curriculum development priorities with business needs
  • Demonstrate a solid understanding and application of adult learning principles and training evaluation
  • Excellent verbal, reading, and writing ability in English
  • An eye for quality and committed focus on customer success, employee success, speed, and doing the right thing
  • Flexible, collaborative, team-oriented individual who shows initiative and holds themselves and others accountable
  • Excellent leadership, communication, and project management skills
  • Ability to develop and foster strong relationships with agencies, customers, and internal teams
  • Aptitude and desire to learn Veeva products administration and become a subject matter expert
  • Ability to communicate to all audiences (and understand the audience and goals) or levels of an organization (written, verbal, formal presentation)
Responsibilities
  • Be a product evangelist and develop subject matter expertise for Veeva Commercial product suite of applications
  • Stay up to date with the latest features, capabilities, and roadmap direction
  • Apply adult learning theory to the design of engaging training experiences and the development of associated learning assets
  • Use modern authoring tools to build, deploy, and update courses and supporting materials in the appropriate interactive formats (instructor-led, video, e-learning, hands-on labs, and assessments)
  • Translate complex technical subjects into clear and concise instruction for both functional and technical users
  • Manage the end-to-end curriculum development process, from initial analysis to design, development, implementation, and evaluation
  • Work cross-functionally with SMEs and stakeholders to validate learning objectives and technical accuracy and incorporate feedback
  • Develop a working knowledge of various capabilities of Veeva products and underlying technologies with the aim of becoming an expert in one or more areas
  • Assist with the creation, configuration, and maintenance of partner development and course lab environments
  • Stay current with industry trends, best practices, and new technologies to enhance training delivery methods
  • Provide solutions and bring innovation to training and enablement strategy and processes
  • Identify opportunities to support customer success
  • Maintain and grow assigned partner relationships through consistent communication, outreach, and support
  • Identify opportunities to support customer success
Desired Qualifications
  • Experience with Veeva products or similar life sciences SaaS platform
  • Previous experience in application administration and product subject matter expertise
  • Additional languages

Veeva Systems offers software solutions for quality, regulatory, and advertising claims management, focusing on consumer products and chemical companies. Their cloud-based platform provides end-to-end visibility and traceability throughout the product journey, ensuring compliance with regulations and accelerating time-to-market. Unlike competitors, Veeva has expanded from the Life Sciences sector to address similar challenges in the Chemical and Consumer Goods markets. The company's goal is to modernize the product journey for clients while maintaining high standards of quality and safety.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Pleasanton, California

Founded

2007

Simplify Jobs

Simplify's Take

What believers are saying

  • Veeva's SiteVault CTMS streamlines clinical trial management for research sites.
  • Indero's success with Veeva RTSM highlights benefits of standardized clinical trial processes.
  • Veeva's global reach includes over 950 customers in 165 countries.

What critics are saying

  • Increased competition from AI-powered solutions like EVERSANA ORCHESTRATE MLR.
  • Potential integration challenges with Flatiron Health in oncology research efforts.
  • Adoption challenges for Veeva SiteVault CTMS due to existing system integration needs.

What makes Veeva Systems unique

  • Veeva Systems specializes in cloud-based software for the life sciences industry.
  • The company offers end-to-end visibility and traceability in product journeys.
  • Veeva's subscription model ensures continuous updates and improvements for clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Parental leave

PTO

Free food

Health, dental, & vision insurance

Gym membership reimbursement

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

0%
Health Technology Insights
Apr 16th, 2025
Flatiron Joins Veeva to Boost Oncology Research Efforts

Flatiron Health, a healthtech company transforming clinical research through solutions that integrate research into everyday care, announced they will partner with Veeva Systems, a global leader in cloud software for the life sciences industry.

PharmiWeb
Apr 11th, 2025
Eversana Unveils Eversana Orchestrate™ Mlr, An Ai-Powered Solution To Transform The Medical, Legal & Regulatory Process

Platform built in collaboration with Amazon Web Services, Modus Create to produce unmatched accuracy, efficiencies and compliance for life science companiesCHICAGO – 10 April, 2025 - EVERSANA, a leading provider of commercial services to the life sciences industry, today announced the next milestone in its journey to transform and innovate commercialization with the launch of EVERSANA ORCHESTRATE MLR, an AI-powered, industry-integrated platform that revolutionizes the Medical, Legal, and Regulatory (MLR) process.EVERSANA ORCHESTRATE MLR automates 90 percent of common tasks in the complex review process through a single platform that’s easy to implement and complies with all regulatory requirements.The solution was built on Amazon Bedrock, which offers a choice of high-performing foundation models. EVERSANA worked with consulting firm Modus Create , EVERSANA’s Medical Affairs and Regulatory Affairs experts, and Veeva for seamless integration with Veeva PromoMats.“EVERSANA ORCHESTRATE MLR is a game-changer for the life science industry,” said Jim Lang, CEO. “Through the power of AI and our collaborations with leading technology providers and in-house MLR experts, we’ve set a new standard for efficiency, compliance, and quality that is much needed in today’s industry.”Shifting the Industry MLR Process from Manual to AutomatedMost organizations have a manual MLR review process, requiring teams to comb through hundreds of marketing materials and cross-reference them with the most accurate regulatory claims information available. EVERSANA ORCHESTRATE MLR automatically identifies, extracts and manages claims in minutes with the power of AI.Additionally, annotation and cross-referencing for creative-type documents against claims data can now be completed in just a few clicks. Users will see all claims identified in the document and what needs to be updated and can make these updates in real-time, resulting in 90 percent faster content updates and an overall reduction in content reviews by as much as 50 percent.By harnessing the power of Amazon Bedrock, EVERSANA will empower life sciences companies with the AI tools they need to mitigate a significant pain point for the healthcare industry— administrative burden. EVERSANA ORCHESTRATE MLR is just one example of how EVERSANA is using industry-leading AI solutions to solve some of healthcare’s most complex problems.“Generative AI is transforming the life sciences industry by accelerating R&D, improving efficiency in manufacturing, and streamlining the path to commercialization," said Dan Sheeran, general manager, Healthcare and Life Sciences, AWS

PR Newswire
Apr 1st, 2025
Veeva Announces Research Site Clinical Trial Management System

Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsorsPLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with SiteVault eISF and SiteVault eConsent to allow sites to comprehensively manage clinical trials within one main system. Integration with sponsors using Veeva's Clinical Platform gives sites seamless bidirectional data flow to sponsors to reduce manual processes and increase efficiency."We need to work efficiently to help more families enroll their children in studies and get lifesaving treatment," said Theresa Oswald, director of research operations and conduct at Ann & Robert H. Lurie Children's Hospital of Chicago. "In our experience, we have found that systems like Veeva SiteVault with a CTMS provide a streamlined user experience. This can help drive speed for the benefit of our patients.""We are excited to bring Veeva SiteVault CTMS to the industry," said Nick Frenzer, general manager, site solutions at Veeva. "High-quality cloud software and seamless sponsor integration will help sites be more efficient

PR Newswire
Mar 19th, 2025
Indero Marks 40Th Study Live With Veeva Rtsm

Specialized CRO standardizes on Veeva RTSM to drive operational efficiency and faster study timelinesBARCELONA, Spain, March 19, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Indero, formerly Innovaderm Research, successfully launched its 40th RTSM study on Veeva RTSM. By standardizing with Veeva RTSM, Indero has strengthened its clinical trial operations, harnessing advanced RTSM capabilities and expert support to drive efficiency, enhance process consistency, and streamline execution."As we continue to optimize our clinical trial operations, Veeva RTSM has driven more efficient processes and closer collaboration to ensure seamless execution," said Eric Hardy, senior director, biometrics at Indero. "Because of this added speed and effectiveness, we can help bring therapies to market faster, allowing our sponsors, sites, and patients to benefit sooner."The launch of Indero's 40th RTSM study highlights the continued collaboration between the two organizations. Since first adopting Veeva RTSM, Indero has worked closely with Veeva to continuously refine and implement standardized processes that drive long-term success for its clinical trials."With its enterprise standard RTSM approach, Indero is achieving greater long-term efficiency and reliability in their studies," said Steve Simmerman, general manager, Veeva RTSM. "Partnering with Indero to standardize clinical processes will further accelerate study timelines, demonstrating a streamlined approach that can advance the industry."Additional InformationTo learn more about Veeva's enterprise standard RTSM, visit www.veeva.com/rtsm.About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs

Stock Titan
Mar 19th, 2025
Indero Marks 40th Study Live with Veeva RTSM

Since first adopting Veeva RTSM, Indero has worked closely with Veeva to continuously refine and implement standardized processes that drive long-term success for its clinical trials.